Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer
Bentzen S M, Saunders M I and Dische S 1999 Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer Radiother. Oncol. 53 219-26
Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix
Eifel P J et al 1995 Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix Int. J. Radiat. Oncol. Biol. Phys. 32 1289-300
Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: Radiobiological and dosimetric considerations
Guerrero M et al 2005 Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations Int. J. Radiat. Oncol. Biol. Phys. 62 933-9
Hunter R D 1994 Dose rate correction in LDR intracavitary therapy Brachytherapy from Radium to Optimisation ed R F Mould, J J Butterman and B L Speiser (Veenendal: Nucletron International BV) pp 55-9
Low dose-rate brachytherapy for treating cervix carcinoma: Changing dose-rate
Hunter R D and Davidson S E 2002 Low dose-rate brachytherapy for treating cervix carcinoma: changing dose-rate Principles and Practice for Brachytherapy ed C Joslin, A Flynn and E J Hall (London: Arnold) pp 343-53
The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix
Nag S et al 2000 The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix Int. J. Radiat. Oncol. Biol. Phys. 48 201-11
Increased morbidity following the introduction of remote afterloading, with increased dose rate, for cancer of the cervix
Newman G 1996 Increased morbidity following the introduction of remote afterloading, with increased dose rate, for cancer of the cervix Radiother. Oncol. 39 97-103
High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissues
Orton C G 2001 High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissues Int. J. Radiat. Oncol. Biol. Phys. 49 183-9
Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: A radiobiological analysis of a randomised clinical trial
Roberts S A et al 2004 Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial Radiother. Oncol. 70 63-74
Clinical trials of changing dose rate in intracavitary low dose rate therapy
Stout R and Hunter R D 1989 Clinical trials of changing dose rate in intracavitary low dose rate therapy Brachytherapy vol 2 ed R F Mould (Veenendal: Nucletron International BV) pp 219-22